Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | GPR3 | P46089 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24601325 | 0.98 | KDM4E (0.48) | KDM4EATML3MBTL1GPR3MAPT | |
| SCHEMBL22178730 | 0.90 | KDM4E (0.47) | KDM4EATML3MBTL1GPR3MAPT | |
| SCHEMBL17995059 | 0.88 | KDM4E (0.48) | KDM4EATML3MBTL1GPR3MAPT | |
| SCHEMBL24601326 | 0.88 | KDM4E (0.48) | KDM4EATML3MBTL1GPR3MAPT | |
| SCHEMBL17146748 | 0.86 | KDM4E (0.47) | KDM4EATML3MBTL1GPR3MAPT | |
| SCHEMBL24601408 | 0.85 | KIF11 (0.38) | KDM4EATML3MBTL1MAPTALDH1A1 | |
| SCHEMBL24601623 | 0.85 | ALKBH5 (0.45) | KDM4EATML3MBTL1MAPTPOLB | |
| SCHEMBL24601424 | 0.85 | PGR (0.35) | KDM4EATML3MBTL1 | |
| SCHEMBL26179742 | 0.85 | KDM4E (0.46) | KDM4EATML3MBTL1GPR3MAPT | |
| SCHEMBL24425621 | 0.85 | KDM4E (0.46) | KDM4EATML3MBTL1GPR3POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200212315-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, ELECTRONIC DEVICE, AND COMPOUND | IDEMITSU KOSAN CO.,LTD. (JP) | 2020-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200212315-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, ELECTRONIC DEVICE, AND COMPOUND | OR10J3, ESR1, NFE2L2 | KDM4E 2780/4885ATM 3269/4885L3MBTL1 713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.